Free Trial

Prenetics Global (PRE) Competitors

Prenetics Global logo
$13.70 +1.31 (+10.57%)
Closing price 04:00 PM Eastern
Extended Trading
$13.65 -0.05 (-0.36%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PRE vs. LAB, CTKB, SENS, QSI, FEIM, MASS, QTRX, OWLT, RPID, and KEQU

Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), 908 Devices (MASS), Quanterix (QTRX), Owlet (OWLT), Rapid Micro Biosystems (RPID), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.

Prenetics Global vs. Its Competitors

Prenetics Global (NASDAQ:PRE) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Prenetics Global had 1 more articles in the media than Standard BioTools. MarketBeat recorded 4 mentions for Prenetics Global and 3 mentions for Standard BioTools. Prenetics Global's average media sentiment score of 1.03 beat Standard BioTools' score of 0.77 indicating that Prenetics Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prenetics Global
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Standard BioTools
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Prenetics Global presently has a consensus target price of $9.00, indicating a potential downside of 34.31%. Standard BioTools has a consensus target price of $1.55, indicating a potential upside of 18.32%. Given Standard BioTools' higher probable upside, analysts clearly believe Standard BioTools is more favorable than Prenetics Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Standard BioTools
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Standard BioTools has a net margin of -69.08% compared to Prenetics Global's net margin of -87.92%. Standard BioTools' return on equity of -20.23% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-87.92% -31.05% -24.16%
Standard BioTools -69.08%-20.23%-15.32%

Prenetics Global has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500.

Prenetics Global has higher earnings, but lower revenue than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$30.62M5.81-$46.30M-$3.99-3.43
Standard BioTools$174.43M2.87-$138.88M-$0.32-4.09

Summary

Standard BioTools beats Prenetics Global on 9 of the 16 factors compared between the two stocks.

Get Prenetics Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRE vs. The Competition

MetricPrenetics GlobalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$177.83M$3.11B$5.74B$10.35B
Dividend YieldN/A2.36%5.53%4.58%
P/E Ratio-3.4320.9076.3526.43
Price / Sales5.81253.83466.9191.04
Price / CashN/A46.3537.4661.85
Price / Book1.049.8313.186.39
Net Income-$46.30M-$52.73M$3.29B$271.22M
7 Day Performance27.80%4.85%2.50%2.78%
1 Month Performance88.97%6.37%4.60%7.35%
1 Year Performance226.19%19.15%73.81%29.64%

Prenetics Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRE
Prenetics Global
0.8079 of 5 stars
$13.70
+10.6%
$9.00
-34.3%
+184.8%$177.83M$30.62M-3.431Positive News
High Trading Volume
LAB
Standard BioTools
2.703 of 5 stars
$1.39
-1.1%
$1.55
+11.9%
-26.2%$529.06M$174.43M-4.33620
CTKB
Cytek Biosciences
1.928 of 5 stars
$3.75
-2.8%
$5.60
+49.2%
-28.5%$475.17M$200.45M-74.70500Positive News
SENS
Senseonics
2.2949 of 5 stars
$0.46
+0.7%
$1.54
+232.8%
+32.6%$376.38M$25.47M-3.5590
QSI
Quantum-Si
1.6211 of 5 stars
$1.58
-7.4%
$3.48
+120.6%
+75.8%$318.93M$3.41M-2.32150News Coverage
Gap Up
FEIM
Frequency Electronics
3.2963 of 5 stars
$29.75
-0.5%
$43.00
+44.6%
+149.5%$290.21M$69.81M13.00200Analyst Downgrade
MASS
908 Devices
2.2621 of 5 stars
$7.57
+0.2%
$8.00
+5.7%
+115.7%$270.38M$59.63M-13.9660
QTRX
Quanterix
1.3002 of 5 stars
$5.46
+0.1%
$11.75
+115.4%
-60.8%$253.49M$137.42M-3.00460
OWLT
Owlet
2.3741 of 5 stars
$8.46
-2.0%
$10.25
+21.2%
+102.7%$144.41M$78.10M-2.42106News Coverage
RPID
Rapid Micro Biosystems
2.9461 of 5 stars
$3.25
-2.6%
$8.00
+145.9%
+276.9%$143.46M$28.05M-3.21200
KEQU
Kewaunee Scientific
0.8386 of 5 stars
$44.54
+1.2%
N/A+31.2%$127.83M$240.47M10.781,239

Related Companies and Tools


This page (NASDAQ:PRE) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners